{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:49:43Z","timestamp":1790794183872,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["8770035"],"award-info":[{"award-number":["8770035"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Patients with neutrophil-mediated asthma have poor response to glucocorticoids. The roles and mechanisms of group 3 innate lymphoid cells (ILC3s) in inducing neutrophilic airway inflammation and glucocorticoid resistance in asthma have not been fully clarified.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>ILC3s in peripheral blood were measured by flow cytometry in patients with eosinophilic asthma (EA) and non-eosinophilic asthma (NEA). ILC3s were sorted and cultured in vitro for RNA sequencing. Cytokines production and signaling pathways in ILC3s after IL-1\u03b2 stimulation and dexamethasone treatment were determined by real-time PCR, flow cytometry, ELISA and western blot.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The percentage and numbers of ILC3s in peripheral blood was higher in patients with NEA compared with EA, and negatively correlated with blood eosinophils. IL-1\u03b2 stimulation significantly enhanced CXCL8 and CXCL1 production in ILC3s via activation of p65 NF-\u03baB and p38\/JNK MAPK signaling pathways. The expression of neutrophil chemoattractants from ILC3s was insensitive to dexamethasone treatment. Dexamethasone significantly increased phosphorylation of glucocorticoid receptor (GR) at Ser226 but only with a weak induction at Ser211 residues in ILC3s. Compared to human bronchial epithelial cell line (16HBE cells), the ratio of p-GR S226 to p-GR S211 (p-GR S226\/S211) was significantly higher in ILC3s at baseline and after dexamethasone treatment. In addition, IL-1\u03b2 could induce Ser226 phosphorylation and had a crosstalk effect to dexamethasone via NF-\u03baB pathway.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>ILC3s were elevated in patients with NEA, and associated with neutrophil inflammation by release of neutrophil chemoattractants and were glucocorticoid (GC) resistant. This paper provides a novel cellular and molecular mechanisms of neutrophil inflammation and GC-resistance in asthma.<\/jats:p>\n                <jats:p><jats:italic>Trial registration<\/jats:italic> The study has been prospectively registered in the World Health Organization International Clinical Trials Registry Platform (ChiCTR1900027125)<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12931-023-02395-5","type":"journal-article","created":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T04:27:59Z","timestamp":1679545679000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Group 3 innate lymphoid cells secret neutrophil chemoattractants and are insensitive to glucocorticoid via aberrant GR phosphorylation"],"prefix":"10.1186","volume":"24","author":[{"given":"Li Xiu","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting Xuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan Lan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9009-065X","authenticated-orcid":false,"given":"Jian","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2241-2474","authenticated-orcid":false,"given":"Chun Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,23]]},"reference":[{"issue":"2","key":"2395_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nri3365","volume":"13","author":"H Spits","year":"2013","unstructured":"Spits H, Artis D, Colonna M, et al. Innate lymphoid cells\u2013a proposal for uniform nomenclature. Nat Rev Immunol. 2013;13(2):145\u20139.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"2395_CR2","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","volume":"174","author":"E Vivier","year":"2018","unstructured":"Vivier E, Artis D, Colonna M, et al. Innate Lymphoid Cells: 10 Years On. Cell. 2018;174(5):1054\u201366.","journal-title":"Cell"},{"issue":"1","key":"2395_CR3","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.it.2015.11.003","volume":"37","author":"CH Kim","year":"2016","unstructured":"Kim CH, Hashimoto-Hill S, Kim M. Migration and tissue tropism of innate lymphoid cells. Trends Immunol. 2016;37(1):68\u201379.","journal-title":"Trends Immunol"},{"issue":"7293","key":"2395_CR4","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1038\/nature08949","volume":"464","author":"S Buonocore","year":"2010","unstructured":"Buonocore S, Ahern PP, Uhlig HH, et al. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature. 2010;464(7293):1371\u20135.","journal-title":"Nature"},{"key":"2395_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3389\/fimmu.2019.00092","volume":"10","author":"A Ardain","year":"2019","unstructured":"Ardain A, Porterfield JZ, Kl\u00f8verpris HN, et al. Type 3 ILCs in lung disease. Front Immunol. 2019;10:92.","journal-title":"Front Immunol"},{"issue":"1","key":"2395_CR6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nm.3423","volume":"20","author":"HY Kim","year":"2014","unstructured":"Kim HY, Lee HJ, Chang YJ, et al. Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat Med. 2014;20(1):54\u201361.","journal-title":"Nat Med"},{"key":"2395_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.849155","volume":"13","author":"AC Jonckheere","year":"2022","unstructured":"Jonckheere AC, Seys SF, Steelant B, et al. Innate lymphoid cells are required to induce airway hyperreactivity in a murine neutrophilic asthma model. Front Immunol. 2022;13: 849155.","journal-title":"Front Immunol"},{"issue":"5","key":"2395_CR8","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1378\/chest.119.5.1329","volume":"119","author":"PG Gibson","year":"2001","unstructured":"Gibson PG, Simpson JL, Saltos N. Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest. 2001;119(5):1329\u201336.","journal-title":"Chest"},{"issue":"7","key":"2395_CR9","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1136\/thorax.57.7.643","volume":"57","author":"J Douwes","year":"2002","unstructured":"Douwes J, Gibson P, Pekkanen J, et al. Non-eosinophilic asthma: importance and possible mechanisms. Thorax. 2002;57(7):643\u20138.","journal-title":"Thorax"},{"issue":"12","key":"2395_CR10","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.it.2017.07.003","volume":"38","author":"A Ray","year":"2017","unstructured":"Ray A, Kolls JK. Neutrophilic inflammation in asthma and association with disease severity. Trends Immunol. 2017;38(12):942\u201354.","journal-title":"Trends Immunol"},{"issue":"10","key":"2395_CR11","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1164\/rccm.201405-0859PP","volume":"190","author":"J Chesn\u00e9","year":"2014","unstructured":"Chesn\u00e9 J, Braza F, Mahay G, et al. IL-17 in severe asthma. Where do we stand? Am J Respir Crit Care Med. 2014;190(10):1094\u2013101.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"2395_CR12","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.4049\/jimmunol.181.6.4089","volume":"181","author":"L McKinley","year":"2008","unstructured":"McKinley L, Alcorn JF, Peterson A, et al. TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J Immunol. 2008;181(6):4089\u201397.","journal-title":"J Immunol"},{"issue":"11","key":"2395_CR13","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1080\/17476348.2019.1666002","volume":"13","author":"RK Ramakrishnan","year":"2019","unstructured":"Ramakrishnan RK, Al HS, Hamid Q. Role of IL-17 in asthma pathogenesis and its implications for the clinic. Expert Rev Respir Med. 2019;13(11):1057\u201368.","journal-title":"Expert Rev Respir Med"},{"key":"2395_CR14","unstructured":"Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2020.\u00a0\u00a0www.ginasthma.org."},{"issue":"9842","key":"2395_CR15","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S0140-6736(12)60988-X","volume":"380","author":"ID Pavord","year":"2012","unstructured":"Pavord ID, Korn S, Howarth P, et al. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet. 2012;380(9842):651\u20139.","journal-title":"Lancet"},{"issue":"10056","key":"2395_CR16","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/S0140-6736(16)31322-8","volume":"388","author":"JM FitzGerald","year":"2016","unstructured":"FitzGerald JM, Bleecker ER, Nair P, et al. Benralizumab, an anti-interleukin-5 receptor \u03b1 monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2016;388(10056):2128\u201341.","journal-title":"Lancet"},{"issue":"5","key":"2395_CR17","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.21037\/jtd.2017.04.74","volume":"9","author":"G Wang","year":"2017","unstructured":"Wang G, Wang F, Gibson PG, et al. Severe and uncontrolled asthma in China: a cross-sectional survey from the Australasian Severe Asthma Network. J Thorac Dis. 2017;9(5):1333\u201344.","journal-title":"J Thorac Dis"},{"issue":"2","key":"2395_CR18","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1164\/rccm.200305-659OC","volume":"170","author":"BG Cos\u00edo","year":"2004","unstructured":"Cos\u00edo BG, Mann B, Ito K, et al. Histone acetylase and deacetylase activity in alveolar macrophages and blood mononocytes in asthma. Am J Respir Crit Care Med. 2004;170(2):141\u20137.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"2395_CR19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/ni.3368","volume":"17","author":"\u00c5K Bj\u00f6rklund","year":"2016","unstructured":"Bj\u00f6rklund \u00c5K, Forkel M, Picelli S, et al. The heterogeneity of human CD127(+) innate lymphoid cells revealed by single-cell RNA sequencing. Nat Immunol. 2016;17(4):451\u201360.","journal-title":"Nat Immunol"},{"issue":"7","key":"2395_CR20","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/ibd\/izaa316","volume":"27","author":"L Mazzurana","year":"2021","unstructured":"Mazzurana L, Bonfiglio F, Forkel M, et al. Crohn\u2019s Disease Is Associated With Activation of Circulating Innate Lymphoid Cells. Inflamm Bowel Dis. 2021;27(7):1128\u201338.","journal-title":"Inflamm Bowel Dis"},{"issue":"9","key":"2395_CR21","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1002\/eji.201848075","volume":"49","author":"L Mazzurana","year":"2019","unstructured":"Mazzurana L, Forkel M, Rao A, et al. Suppression of Aiolos and Ikaros expression by lenalidomide reduces human ILC3-ILC1\/NK cell transdifferentiation. Eur J Immunol. 2019;49(9):1344\u201355.","journal-title":"Eur J Immunol"},{"issue":"11","key":"2395_CR22","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/ni.2104","volume":"12","author":"JM Mj\u00f6sberg","year":"2011","unstructured":"Mj\u00f6sberg JM, Trifari S, Crellin NK, et al. Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol. 2011;12(11):1055\u201362.","journal-title":"Nat Immunol"},{"issue":"6","key":"2395_CR23","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1016\/j.jaci.2019.08.008","volume":"144","author":"J Luo","year":"2019","unstructured":"Luo J, Wu Y, Shrimanker R, et al. Resistance to apoptosis underpins the corticosteroid insensitivity of group 2 innate lymphoid cells. J Allergy Clin Immunol. 2019;144(6):1722\u20136.","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"2395_CR24","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1002\/cyto.a.20815","volume":"75","author":"JP Law","year":"2009","unstructured":"Law JP, Hirschkorn DF, Owen RE, et al. The importance of Foxp3 antibody and fixation\/permeabilization buffer combinations in identifying CD4+CD25+Foxp3+ regulatory T cells. Cytometry A. 2009;75(12):1040\u201350.","journal-title":"Cytometry A"},{"issue":"1","key":"2395_CR25","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1038\/s41598-021-81642-5","volume":"11","author":"J Wei","year":"2021","unstructured":"Wei J, Shi Q, Xiong L, et al. Transcriptome profiling of cells exposed to particular and intense electromagnetic radiation emitted by the \u201cSG-III\u201d prototype laser facility. Sci Rep. 2021;11(1):2017.","journal-title":"Sci Rep"},{"key":"2395_CR26","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13045-016-0269-y","volume":"9","author":"X Li","year":"2016","unstructured":"Li X, Wang S, Zhu R, et al. Lung tumor exosomes induce a pro-inflammatory phenotype in mesenchymal stem cells via NF\u03baB-TLR signaling pathway. J Hematol Oncol. 2016;9:42.","journal-title":"J Hematol Oncol"},{"issue":"7436","key":"2395_CR27","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nature11813","volume":"494","author":"CS Klose","year":"2013","unstructured":"Klose CS, Kiss EA, Schwierzeck V, et al. A T-bet gradient controls the fate and function of CCR6-ROR\u03b3t+ innate lymphoid cells. Nature. 2013;494(7436):261\u20135.","journal-title":"Nature"},{"issue":"5","key":"2395_CR28","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.immuni.2010.10.012","volume":"33","author":"NK Crellin","year":"2010","unstructured":"Crellin NK, Trifari S, Kaplan CD, et al. Regulation of cytokine secretion in human CD127(+) LTi-like innate lymphoid cells by Toll-like receptor 2. Immunity. 2010;33(5):752\u201364.","journal-title":"Immunity"},{"issue":"10","key":"2395_CR29","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.3324\/haematol.2009.006973","volume":"94","author":"T Loos","year":"2009","unstructured":"Loos T, Opdenakker G, Van Damme J, et al. Citrullination of CXCL8 increases this chemokine\u2019s ability to mobilize neutrophils into the blood circulation. Haematologica. 2009;94(10):1346\u201353.","journal-title":"Haematologica"},{"issue":"3","key":"2395_CR30","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.4049\/jimmunol.155.3.1428","volume":"155","author":"ME Hammond","year":"1995","unstructured":"Hammond ME, Lapointe GR, Feucht PH, et al. IL-8 induces neutrophil chemotaxis predominantly via type I IL-8 receptors. J Immunol. 1995;155(3):1428\u201333.","journal-title":"J Immunol"},{"issue":"9","key":"2395_CR31","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1038\/jid.2014.146","volume":"134","author":"M Teunissen","year":"2014","unstructured":"Teunissen M, Munneke JM, Bernink JH, et al. Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR(+) ILC3 in lesional skin and blood of psoriasis patients. J Invest Dermatol. 2014;134(9):2351\u201360.","journal-title":"J Invest Dermatol"},{"issue":"8","key":"2395_CR32","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1002\/eji.201445213","volume":"45","author":"YO Ahn","year":"2015","unstructured":"Ahn YO, Weeres MA, Neulen ML, et al. Human group3 innate lymphoid cells express DR3 and respond to TL1A with enhanced IL-22 production and IL-2-dependent proliferation. Eur J Immunol. 2015;45(8):2335\u201342.","journal-title":"Eur J Immunol"},{"issue":"2","key":"2395_CR33","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.immuni.2009.08.001","volume":"31","author":"CE Sutton","year":"2009","unstructured":"Sutton CE, Lalor SJ, Sweeney CM, et al. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity. 2009;31(2):331\u201341.","journal-title":"Immunity"},{"issue":"3","key":"2395_CR34","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.jaci.2015.01.026","volume":"136","author":"ES Chambers","year":"2015","unstructured":"Chambers ES, Nanzer AM, Pfeffer PE, et al. Distinct endotypes of steroid-resistant asthma characterized by IL-17A(high) and IFN-\u03b3(high) immunophenotypes: Potential benefits of calcitriol. J Allergy Clin Immunol. 2015;136(3):628\u201337.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"2395_CR35","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1440-1843.2011.02097.x","volume":"17","author":"JS Choi","year":"2012","unstructured":"Choi JS, Jang AS, Park JS, et al. Role of neutrophils in persistent airway obstruction due to refractory asthma. Respirology. 2012;17(2):322\u20139.","journal-title":"Respirology"},{"issue":"6","key":"2395_CR36","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1378\/chest.07-1047","volume":"132","author":"DE Shaw","year":"2007","unstructured":"Shaw DE, Berry MA, Hargadon B, et al. Association between neutrophilic airway inflammation and airflow limitation in adults with asthma. Chest. 2007;132(6):1871\u20135.","journal-title":"Chest"},{"key":"2395_CR37","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.3389\/fimmu.2019.01545","volume":"10","author":"S Timmermans","year":"2019","unstructured":"Timmermans S, Souffriau J, Libert C. A general introduction to glucocorticoid biology. Front Immunol. 2019;10:1545.","journal-title":"Front Immunol"},{"issue":"4","key":"2395_CR38","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.tem.2018.01.010","volume":"29","author":"T Kino","year":"2018","unstructured":"Kino T. GR-regulating serine\/threonine kinases: new physiologic and pathologic implications. Trends Endocrinol Metab. 2018;29(4):260\u201370.","journal-title":"Trends Endocrinol Metab"},{"issue":"2","key":"2395_CR39","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.immuni.2017.07.025","volume":"47","author":"M Fasolino","year":"2017","unstructured":"Fasolino M, Vahedi G. GR extinguishes inflamed chromatin, and NF-\u03baB evacuates. Immunity. 2017;47(2):214\u20136.","journal-title":"Immunity"},{"issue":"5","key":"2395_CR40","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.jaci.2016.03.019","volume":"138","author":"L Everaere","year":"2016","unstructured":"Everaere L, Ait-Yahia S, Molendi-Coste O, et al. Innate lymphoid cells contribute to allergic airway disease exacerbation by obesity. J Allergy Clin Immunol. 2016;138(5):1309\u201318.","journal-title":"J Allergy Clin Immunol"},{"key":"2395_CR41","doi-asserted-by":"publisher","first-page":"1628620","DOI":"10.1155\/2018\/1628620","volume":"2018","author":"Y Wu","year":"2018","unstructured":"Wu Y, Yue J, Wu J, et al. Obesity may provide Pro-ILC3 development inflammatory environment in asthmatic children. J Immunol Res. 2018;2018:1628620.","journal-title":"J Immunol Res"},{"issue":"1","key":"2395_CR42","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/ACI.0000000000000497","volume":"19","author":"AC Jonckheere","year":"2019","unstructured":"Jonckheere AC, Bullens D, Seys SF. Innate lymphoid cells in asthma: pathophysiological insights from murine models to human asthma phenotypes. Curr Opin Allergy Clin Immunol. 2019;19(1):53\u201360.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"2395_CR43","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1164\/rccm.201212-2318OC","volume":"188","author":"WW Busse","year":"2013","unstructured":"Busse WW, Holgate S, Kerwin E, et al. Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma. Am J Respir Crit Care Med. 2013;188:1294\u2013302.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"2395_CR44","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1006\/cimm.1996.0235","volume":"172","author":"JT Mao","year":"1996","unstructured":"Mao JT, Huang M, Wang J, et al. Cocaine down-regulates IL-2-induced peripheral blood lymphocyte IL-8 and IFN-gamma production. Cell Immunol. 1996;172(2):217\u201323.","journal-title":"Cell Immunol"},{"issue":"5","key":"2395_CR45","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.4049\/jimmunol.151.5.2725","volume":"151","author":"GL Gusella","year":"1993","unstructured":"Gusella GL, Musso T, Bosco MC, et al. IL-2 up-regulates but IFN-gamma suppresses IL-8 expression in human monocytes. J Immunol. 1993;151(5):2725\u201332.","journal-title":"J Immunol"},{"key":"2395_CR46","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2147\/JAA.S153097","volume":"11","author":"I Esteban-Gorgojo","year":"2018","unstructured":"Esteban-Gorgojo I, Antol\u00edn-Am\u00e9rigo D, Dom\u00ednguez-Ortega J, et al. Non-eosinophilic asthma: current perspectives. J Asthma Allergy. 2018;11:267\u201381.","journal-title":"J Asthma Allergy"},{"issue":"10","key":"2395_CR47","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1002\/iub.245","volume":"61","author":"AJ Galliher-Beckley","year":"2009","unstructured":"Galliher-Beckley AJ, Cidlowski JA. Emerging roles of glucocorticoid receptor phosphorylation in modulating glucocorticoid hormone action in health and disease. IUBMB Life. 2009;61(10):979\u201386.","journal-title":"IUBMB Life"},{"key":"2395_CR48","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1475-2867-7-3","volume":"7","author":"AL Miller","year":"2007","unstructured":"Miller AL, Garza AS, Johnson BH, et al. Pathway interactions between MAPKs, mTOR, PKA, and the glucocorticoid receptor in lymphoid cells. Cancer Cell Int. 2007;7:3.","journal-title":"Cancer Cell Int"},{"issue":"5","key":"2395_CR49","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.21037\/jtd-20-213","volume":"12","author":"D Wu","year":"2020","unstructured":"Wu D, Gu B, Qian Y, et al. Long non-coding RNA growth arrest specific-5: a potential biomarker for early diagnosis of severe asthma. J Thorac Dis. 2020;12(5):1960\u201371.","journal-title":"J Thorac Dis"},{"issue":"12","key":"2395_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0027627","volume":"6","author":"Y Kobayashi","year":"2011","unstructured":"Kobayashi Y, Mercado N, Barnes PJ, et al. Defects of protein phosphatase 2A causes corticosteroid insensitivity in severe asthma. PLoS ONE. 2011;6(12): e27627.","journal-title":"PLoS ONE"},{"issue":"6","key":"2395_CR51","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1210\/me.2004-0528","volume":"19","author":"AL Miller","year":"2005","unstructured":"Miller AL, Webb MS, Copik AJ, et al. p38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211. Mol Endocrinol. 2005;19(6):1569\u201383.","journal-title":"Mol Endocrinol"},{"issue":"10","key":"2395_CR52","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1210\/me.2002-0144","volume":"16","author":"M Itoh","year":"2002","unstructured":"Itoh M, Adachi M, Yasui H, et al. Nuclear export of glucocorticoid receptor is enhanced by c-Jun N-terminal kinase-mediated phosphorylation. Mol Endocrinol. 2002;16(10):2382\u201392.","journal-title":"Mol Endocrinol"},{"issue":"22","key":"2395_CR53","doi-asserted-by":"publisher","first-page":"19297","DOI":"10.1074\/jbc.M110.193672","volume":"286","author":"NJ Verhoog","year":"2011","unstructured":"Verhoog NJ, Du Toit A, Avenant C, et al. Glucocorticoid-independent repression of tumor necrosis factor (TNF) alpha-stimulated interleukin (IL)-6 expression by the glucocorticoid receptor: a  potential mechanism for protection against an excessive inflammatory response. J Biol Chem. 2011;286(22):19297\u2013310.","journal-title":"J Biol Chem."},{"issue":"4","key":"2395_CR54","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1046\/j.1440-1711.2001.01025.x","volume":"79","author":"IM Adcock","year":"2001","unstructured":"Adcock IM, Caramori G. Cross-talk between pro-inflammatory transcription factors and glucocorticoids. Immunol Cell Biol. 2001;79(4):376\u201384.","journal-title":"Immunol Cell Biol"},{"issue":"8","key":"2395_CR55","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1042\/CS20130149","volume":"126","author":"DL Clarke","year":"2014","unstructured":"Clarke DL, Davis NH, Majithiya JB, et al. Development of a mouse model mimicking key aspects of a viral asthma exacerbation. Clin Sci. 2014;126(8):567\u201380.","journal-title":"Clin Sci"},{"issue":"5","key":"2395_CR56","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.4049\/jimmunol.1300104","volume":"191","author":"L Chachi","year":"2013","unstructured":"Chachi L, Shikotra A, Duffy SM, et al. Functional KCa31 channels regulate steroid insensitivity in bronchial smooth muscle cells. J Immunol. 2013;191(5):2624\u201336.","journal-title":"J Immunol"},{"issue":"4","key":"2395_CR57","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1165\/rcmb.2011-0364OC","volume":"47","author":"B Bouazza","year":"2012","unstructured":"Bouazza B, Krytska K, Debba-Pavard M, et al. Cytokines alter glucocorticoid receptor phosphorylation in airway cells: role of phosphatases. Am J Respir Cell Mol Biol. 2012;47(4):464\u201373.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2395_CR58","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1196\/annals.1321.007","volume":"1024","author":"N Ismaili","year":"2004","unstructured":"Ismaili N, Garabedian MJ. Modulation of glucocorticoid receptor function via phosphorylation. Ann N Y Acad Sci. 2004;1024:86\u2013101.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"2395_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0145961","volume":"11","author":"KC De Grove","year":"2016","unstructured":"De Grove KC, Provoost S, Verhamme FM, et al. Characterization and quantification of innate lymphoid cell subsets in human lung. PLoS ONE. 2016;11(1): e145961.","journal-title":"PLoS ONE"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-023-02395-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-023-02395-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-023-02395-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T05:04:26Z","timestamp":1679547866000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-023-02395-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,23]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2395"],"URL":"https:\/\/doi.org\/10.1186\/s12931-023-02395-5","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,23]]},"assertion":[{"value":"2 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board (IRB) at West China Hospital, Sichuan University (Chengdu, China) (No. 2019\u2013856). All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"90"}}